The Sequential Organ Failure Assessment score and copeptin for predicting survival in ventilator-associated pneumonia

Journal of Critical Care

Volumn 27, Issue 5, 2012, Pages 523.e1-523.e9

  Boeck, Lucas ^a   Eggimann, Philippe ^b   Smyrnios, Nicholas ^c   Pargger, Hans ^a   Thakkar, Nehal ^c   Siegemund, Martin ^a   Morgenthaler, Nils G ^d   Rakic, Janko ^a   Tamm, Michael ^a   Stolz, Daiana ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c UMASS MEMORIAL MEDICAL CENTER   (United States)

^d Research Department Brahms AG   (Germany)

Author keywords

Biomarker; Infection; Prognosis

Indexed keywords

COPEPTIN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; COPEPTIN BLOOD LEVEL; DEATH; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PREDICTION; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; SCORING SYSTEM; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SURVIVAL; SURVIVAL TIME; SURVIVOR; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 84867335557     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2011.07.081     Document Type: Article

References (36)

1. Kahn J.M., Goss C.H., Heagerty P.J., Kramer A.A., O'Brien C.R., Rubenfeld G.D. Hospital volume and the outcomes of mechanical ventilation. N Engl J Med 2006, 355(1):41-50.
2. Chastre J., Fagon J.Y. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002, 165(7):867-903.
3. Cook D.J., Walter S.D., Cook R.J., Griffith L.E., Guyatt G.H., Leasa D., et al. Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med 1998, 129(6):433-440.
4. Langer M., Mosconi P., Cigada M., Mandelli M. Long-term respiratory support and risk of pneumonia in critically ill patients. Intensive Care Unit Group of Infection Control. Am Rev Respir Dis 1989, 140(2):302-305.
5. Terragni P.P, Antonelli M., Fumagalli R., Faggiano C., Berardino M., Pallavicini F.B., et al. Early vs late tracheotomy for prevention of pneumonia in mechanically ventilated adult ICU patients: a randomized controlled trial. JAMA 2010, 303(15):1483-1489.
6. Rello J., Ollendorf D.A., Oster G., Vera-Llonch M., Bellm L., Redman R., et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002, 122(6):2115-2121.
7. Murray L.S., Teasdale G.M., Murray G.D., Jennett B., Miller J.D., Pickard J.D., et al. Does prediction of outcome alter patient management?. Lancet 1993, 341(8859):1487-1491.
8. Eichacker P.Q., Parent C., Kalil A., Esposito C., Cui X., Banks S.M., et al. Risk and the efficacy of antiinflammatory agents: retrospective and confirmatory studies of sepsis. Am J Respir Crit Care Med 2002, 166(9):1197-1205.
9. Angus D.C., Laterre P.F., Helterbrand J., Ely E.W., Ball D.E., Garg R., et al. The effect of drotrecogin alfa (activated) on long-term survival after severe sepsis. Crit Care Med 2004, 32(11):2199-2206.
10. Knaus W.A., Draper E.A., Wagner D.P., Zimmerman J.E. APACHE II: a severity of disease classification system. Crit Care Med 1985, 13(10):818-829.
11. Vincent J.L., Moreno R., Takala J., Willatts S., De Mendonca A., Bruining H., et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996, 22(7):707-710.
12. Minne L., Abu-Hanna A., de Jonge E. Evaluation of SOFA-based models for predicting mortality in the ICU: a systematic review. Crit Care 2008, 12(6):R161.
13. Ferreira F.L., Bota D.P., Bross A., Melot C., Vincent J.L. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 2001, 286(14):1754-1758.
14. Morgenthaler N.G., Struck J., Alonso C., Bergmann A. Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem 2006, 52(1):112-119.
15. Holmes C.L., Patel B.M., Russell J.A., Walley K.R. Physiology of vasopressin relevant to management of septic shock. Chest 2001, 120(3):989-1002.
16. Morgenthaler N.G., Struck J., Jochberger S., Dunser M.W. Copeptin: clinical use of a new biomarker. Trends Endocrinol Metab 2008, 19(2):43-49.
17. Reichlin T., Hochholzer W., Stelzig C., Laule K., Freidank H., Morgenthaler N.G., et al. Incremental value of copeptin for rapid rule out of acute myocardial infarction. J Am Coll Cardiol 2009, 54(1):60-68.
18. Katan M., Fluri F., Morgenthaler N.G., Schuetz P., Zweifel C., Bingisser R., et al. Copeptin: a novel, independent prognostic marker in patients with ischemic stroke. Ann Neurol 2009, 66(6):799-808.
19. Muller B., Morgenthaler N., Stolz D., Schuetz P., Muller C., Bingisser R., et al. Circulating levels of copeptin, a novel biomarker, in lower respiratory tract infections. Eur J Clin Invest 2007, 37(2):145-152.
20. Seligman R., Papassotiriou J., Morgenthaler N.G., Meisner M., Teixeira P.J. Copeptin, a novel prognostic biomarker in ventilator-associated pneumonia. Crit Care 2008, 12(1):R11.
21. Stolz D., Christ-Crain M., Morgenthaler N.G., Leuppi J., Miedinger D., Bingisser R., et al. Copeptin, C-reactive protein, and procalcitonin as prognostic biomarkers in acute exacerbation of COPD. Chest 2007, 131(4):1058-1067.
22. Jochberger S., Velik-Salchner C., Mayr V.D., Luckner G., Wenzel V., Falkensammer G., et al. The vasopressin and copeptin response in patients with vasodilatory shock after cardiac surgery: a prospective, controlled study. Intensive Care Med 2009, 35(3):489-497.
23. Stolz D., Smyrnios N., Eggimann P., Pargger H., Thakkar N., Siegemund M., et al. Procalcitonin for reduced antibiotic exposure in ventilator associated pneumonia-a randomized study. Eur Respir J 2009.
24. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005, 171(4):388-416.
25. Fabregas N., Ewig S., Torres A., El-Ebiary M., Ramirez J., de La Bellacasa J.P., et al. Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies. Thorax 1999, 54(10):867-873.
26. Fenske W., Stork S., Blechschmidt A., Maier S.G., Morgenthaler N.G., Allolio B. Copeptin in the differential diagnosis of hyponatremia. J Clin Endocrinol Metab 2009, 94(1):123-129.
27. Harrell F.E. Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis 2001, Springer, New York.
28. Gursel G., Demirtas S. Value of APACHE II, SOFA and CPIS scores in predicting prognosis in patients with ventilator-associated pneumonia. Respiration 2006, 73(4):503-508.
29. Vincent J.L., de Mendonca A., Cantraine F., Moreno R., Takala J., Suter P.M., et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med 1998, 26(11):1793-1800.
30. Chikanza I.C., Petrou P., Chrousos G. Perturbations of arginine vasopressin secretion during inflammatory stress. Pathophysiologic implications. Ann N Y Acad Sci 2000, 917:825-834.
31. Stoiser B., Mortl D., Hulsmann M., Berger R., Struck J., Morgenthaler N.G., et al. Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure. Eur J Clin Invest 2006, 36(11):771-778.
32. Kruger S., Papassotiriou J., Marre R., Richter K., Schumann C., von Baum H., et al. Pro-atrial natriuretic peptide and pro-vasopressin to predict severity and prognosis in community-acquired pneumonia: results from the German competence network CAPNETZ. Intensive Care Med 2007, 33(12):2069-2078.
33. Morgenthaler N.G., Muller B., Struck J., Bergmann A., Redl H., Christ-Crain M. Copeptin, a stable peptide of the arginine vasopressin precursor, is elevated in hemorrhagic and septic shock. Shock 2007, 28(2):219-226.
34. Vincent J.L., Opal S.M., Marshall J.C. Ten reasons why we should NOT use severity scores as entry criteria for clinical trials or in our treatment decisions. Crit Care Med 2010, 38(1):283-287.
35. Cohen N.H. The real reasons not to rely on severity scores. Crit Care Med 2010, 38(1):334-335.
36. Fagon J.Y., Chastre J., Wolff M., Gervais C., Parer-Aubas S., Stephan F., et al. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial. Ann Intern Med 2000, 132(8):621-630.